SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-282064
Filing Date
2022-11-10
Accepted
2022-11-10 09:18:41
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 d258104ds3.htm S-3 463206
2 EX-1.2 d258104dex12.htm EX-1.2 211850
3 EX-4.4 d258104dex44.htm EX-4.4 285905
4 EX-4.6 d258104dex46.htm EX-4.6 95096
5 EX-4.7 d258104dex47.htm EX-4.7 98378
6 EX-4.8 d258104dex48.htm EX-4.8 84169
7 EX-5.1 d258104dex51.htm EX-5.1 28733
8 EX-23.1 d258104dex231.htm EX-23.1 1756
9 EX-FILING FEES d258104dexfilingfees.htm EX-FILING FEES 39491
10 GRAPHIC g258104g04a01.jpg GRAPHIC 587654
11 GRAPHIC g258104g1107160511524.jpg GRAPHIC 2409
12 GRAPHIC g258104g43a02.jpg GRAPHIC 589720
13 GRAPHIC g258104g63a03.jpg GRAPHIC 605558
  Complete submission text file 0001193125-22-282064.txt   3745644
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268288 | Film No.: 221375287
SIC: 2836 Biological Products, (No Diagnostic Substances)